FRTX : Insider Transactions for Fresh Tracks Therapeutics Ord Shs | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Fresh Tracks Therapeutics Ord Shs (FRTX)

$0.68 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

53,520,000

Market Cap:

36.18(M)

Last Volume:

446,593

Avg Vol:

445,352

52 Week Range:

$0.676 - $0.676

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

NASDAQ COMPOSITE

NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year


Company Profile

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	375,704	572,704	572,704	572,704
Total Buy Value	$340,817	$520,870	$520,870	$520,870
Total People Bought	1	1	1	1
Total Buy Transactions	23	31	31	31
Total Shares Sold	0	30,110	30,110	30,110
Total Sell Value	$0	$26,460	$26,460	$26,460
Total People Sold	0	2	2	2
Total Sell Transactions	0	5	5	5
End Date	2024-02-08	2023-11-07	2023-05-09	2022-05-09

Adjust Filter Settings

Records found: 258

Page 10 of 11

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Ramos Anthony Alan

VP, Chief Accounting Officer

• – –

2015-04-23

4

AS

$1.01

$195

D/D

(193)

147,315

-

President & CEO

• • –

2015-04-13

4

AS

$0.93

$4,411

D/D

(4,738)

1,151,038

-

Smith Lawrence Russell

VP, Vaccine Research

• – –

2015-04-13

4

AS

$0.93

$909

D/D

(974)

244,003

-

Sr VP, Corporate Development

• – –

2015-04-13

4

AS

$0.93

$1,173

D/D

(1,257)

195,056

-

President & CEO

• • –

2015-03-30

4

AS

$0.91

$50,149

D/D

(55,000)

1,155,776

-

Ramos Anthony Alan

VP, Chief Accounting Officer

• – –

2015-01-21

4

AS

$1.09

$467

D/D

(428)

147,508

-

Ramos Anthony Alan

VP, Chief Accounting Officer

• – –

2015-01-19

4

A

$0.01

$600

D/D

60,000

147,936

-

Sr VP, Corporate Development

• – –

2015-01-19

4

A

$0.01

$700

D/D

70,000

196,313

-

President & CEO

• • –

2015-01-19

4

A

$0.01

$3,000

D/D

300,000

1,210,776

-

Smith Lawrence Russell

VP, Vaccine Research

• – –

2015-01-19

4

A

$0.01

$700

D/D

70,000

244,977

-

President & CEO

• • –

2015-01-13

4

AS

$1.12

$5,312

D/D

(4,737)

910,776

-

Smith Lawrence Russell

VP, Vaccine Research

• – –

2015-01-12

4

AS

$1.16

$2,210

D/D

(1,912)

174,977

-

Sr VP, Corporate Development

• – –

2015-01-12

4

AS

$1.16

$1,544

D/D

(1,335)

126,313

-

President & CEO

• • –

2014-12-26

4

GD

$0.00

$0

D/D

5,300

915,513

-

President & CEO

• • –

2014-12-23

4

GD

$0.00

$0

D/D

321

920,813

-

President & CEO

• • –

2014-12-22

4

GD

$0.00

$0

D/D

15,379

921,134

-

Ramos Anthony Alan

VP, Chief Accounting Officer

• – –

2014-10-21

4

AS

$1.18

$505

D/D

(428)

87,936

-

President & CEO

• • –

2014-10-13

4

AS

$1.13

$5,353

D/D

(4,738)

936,513

-

Sr VP, Corporate Development

• – –

2014-10-13

4

AS

$1.08

$1,446

D/D

(1,335)

127,648

-

Smith Lawrence Russell

VP, Vaccine Research

• – –

2014-10-13

4

AS

$1.08

$2,067

D/D

(1,912)

176,889

-

Ramos Anthony Alan

VP, Chief Accounting Officer

• – –

2014-08-26

4

AS

$1.25

$15,675

D/D

(12,500)

88,364

-

Smith Lawrence Russell

VP, Vaccine Research

• – –

2014-08-26

4

AS

$1.25

$15,674

D/D

(12,500)

178,801

-

Senior VP, Corporate Devt

• – –

2014-08-26

4

AS

$1.25

$15,671

D/D

(12,500)

128,983

-

Ramos Anthony Alan

VP, Chief Accounting Officer

• – –

2014-07-21

4

AS

$1.29

$552

D/D

(428)

100,864

-

President & CEO

• • –

2014-07-14

4

AS

$1.17

$5,544

D/D

(4,737)

941,251

-

258 Records found	Previous 10 11	Page 10 of 11

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.